ALK fusion in a cohort of 469 Finnish patients with non-small cell lung cancer

被引：0
|
作者：
Merkkiniemi, K. [1 ]
Kero, M. [2 ]
Maki-Nevala, S. [1 ]
Sarhadi, V. K. [1 ]
Tikkanen, M. [1 ]
Wirtanen, T. [1 ]
Ronty, M. [2 ]
Knuuttila, A. [3 ]
Knuutila, S. [1 ]
机构：
[1] Haartman Inst, Dept Pathol, Helsinki, Finland
[2] HUSLAB Helsinki Univ, Cent Hosp, Dept Pathol, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Heart & Lung Ctr, Dept Pulm Med, Helsinki, Finland
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
672
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [31] The fusion gene landscape in Chinese patients with non-small cell lung cancer
    Lin, Qiuju
    Fu, Zhichao
    CANCER RESEARCH, 2022, 82 (12)
  • [32] The Fusion Gene Landscape in Taiwanese Patients with Non-Small Cell Lung Cancer
    Chang, Ya-Sian
    Tu, Siang-Jyun
    Yen, Ju-Chen
    Lee, Ya-Ting
    Fang, Hsin-Yuan
    Chang, Jan-Gowth
    CANCERS, 2021, 13 (06) : 1 - 13
  • [33] Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancer
    Tao, Hong
    Shi, Liang
    Zhou, Aoxue
    Li, Hongxia
    Gai, Fei
    Huang, Zhan
    Che, Nanying
    Liu, Zhe
    LUNG CANCER, 2020, 149 : 154 - 161
  • [34] An effective enrichment strategy for EML4-ALK fusion gene screening in patients with non-small cell lung cancer
    Kobayashi, Makoto
    Sakakibara, Tomohiro
    Inoue, Akira
    Fukuhara, Tatsuro
    Sasano, Hironobu
    Ichinose, Masakazu
    Nukiwa, Toshihiro
    RESPIRATORY INVESTIGATION, 2014, 52 (01) : 49 - 56
  • [35] Unique molecular features and clinical outcomes in young patients with non-small cell lung cancer harboring ALK fusion genes
    Panwen Tian
    Yujie Liu
    Hao Zeng
    Yuan Tang
    Analyn Lizaso
    Junyi Ye
    Lin Shao
    Yalun Li
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 935 - 944
  • [36] FACTORS ASSOCIATED WITH CRIZOTINIB EFFICACY IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER HARBORING DIFFERENT ALK FUSION VARIANTS
    Lin, Yen-Ting
    Shih, Jin-Yuan
    RESPIROLOGY, 2018, 23 : 288 - 289
  • [37] Unique molecular features and clinical outcomes in young patients with non-small cell lung cancer harboring ALK fusion genes
    Tian, Panwen
    Liu, Yujie
    Zeng, Hao
    Tang, Yuan
    Lizaso, Analyn
    Ye, Junyi
    Shao, Lin
    Li, Yalun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (04) : 935 - 944
  • [38] Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib
    Yudong Su
    Xiang Long
    Yang Song
    Peng Chen
    Shanqing Li
    Huaxia Yang
    Pancheng Wu
    Yanyu Wang
    Zhongxing Bing
    Zhili Cao
    Lei Cao
    Yijun Wu
    Zhe Zhang
    Jing Liu
    Bing Li
    Jianxing Xiang
    Ke Ma
    Tengfei Zhang
    Lu Zhang
    Xinru Mao
    Hao Liu
    Puyuan Xing
    Naixin Liang
    Targeted Oncology, 2019, 14 : 159 - 168
  • [39] Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib
    Su, Yudong
    Long, Xiang
    Song, Yang
    Chen, Peng
    Li, Shanqing
    Yang, Huaxia
    Wu, Pancheng
    Wang, Yanyu
    Bing, Zhongxing
    Cao, Zhili
    Cao, Lei
    Wu, Yijun
    Zhang, Zhe
    Liu, Jing
    Li, Bing
    Xiang, Jianxing
    Ma, Ke
    Zhang, Tengfei
    Zhang, Lu
    Mao, Xinru
    Liu, Hao
    Xing, Puyuan
    Liang, Naixin
    TARGETED ONCOLOGY, 2019, 14 (02) : 159 - 168
  • [40] CNS activity of ensartinib in ALK-positive non-small cell lung cancer patients
    Horn, Leora
    Reckamp, Karen L.
    Patel, Sandip
    Blumenschein, George
    Neal, Joel W.
    Gitlitz, Barbara
    Waqar, Saiama
    Oxnard, Geoffrey
    Brzezniak, Christina
    Dukart, Gary
    Tan, Fenlai
    Harrow, Kimberly
    Liang, Chris
    Gibbons, James
    Wakelee, Heather A.
    CANCER RESEARCH, 2017, 77
12345